» Articles » PMID: 9164948

Sequential Development of Structural and Functional Alterations in T Cells from Tumor-bearing Mice

Overview
Journal J Immunol
Date 1997 Jun 1
PMID 9164948
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The TCR alpha beta or -gamma delta chains bind the peptide ligand, whereas the associated CD3 delta epsilon gamma and TCR zeta subunits couple the TCR to intracellular signal transduction components. Recently, several groups have described marked alterations in signal transduction elements in T cells from cancer patients or in mice bearing tumor for a few weeks (>26 days). The sequence in which these alterations develop is unknown. The aim of this study was to explore the kinetics of the development of alterations in signal transduction molecules (TCR zeta chain, NF kappaB family proteins, and tyrosine kinase p56(lck)) in mice bearing MC38 colon adenocarcinoma. The results demonstrate that alterations in NF kappaB family proteins, specifically the failure of p65 translocation to the nucleus, occur earlier and more frequently than the decrease in zeta-chain. These defects are paralleled by an impaired ability to produce Th1 cytokines (IL-2 and IFN-gamma). These initial changes are followed by the eventual loss of TCR zeta chain and p56(lck) and a marked decrease in cytotoxic function. An increased rate of lysosomal degradation is one of the mechanisms responsible for the loss of zeta-chain.

Citing Articles

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

Evaristo C, Spranger S, Barnes S, Miller M, Molinero L, Locke F J Immunol. 2016; 196(7):2933-8.

PMID: 26903482 PMC: 4799771. DOI: 10.4049/jimmunol.1501144.


T cell-NF-κB activation is required for tumor control in vivo.

Barnes S, Wang Y, Chen L, Molinero L, Gajewski T, Evaristo C J Immunother Cancer. 2015; 3(1):1.

PMID: 25648675 PMC: 4308877. DOI: 10.1186/s40425-014-0045-x.


Tumor-primed NK cells: waiting for the green light.

Sabry M, Lowdell M Front Immunol. 2013; 4:408.

PMID: 24324471 PMC: 3838973. DOI: 10.3389/fimmu.2013.00408.


Covert operations: cancer's many subversive tactics in overcoming host defenses.

Longo D Trans Am Clin Climatol Assoc. 2013; 124:163-73.

PMID: 23874020 PMC: 3715908.


Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma.

Miller C, Graham L, Bear H BMC Immunol. 2010; 11:54.

PMID: 21050466 PMC: 2998465. DOI: 10.1186/1471-2172-11-54.